by clicking the arrows at the side of the page, or by using the toolbar.
by clicking anywhere on the page.
by dragging the page around when zoomed in.
by clicking anywhere on the page when zoomed in.
web sites or send emails by clicking on hyperlinks.
Bio Technology : July 2009
AusBioSTATES Tasmania Tasmania’s State Government is currently developing a whole-of-government policy for bioprospecting in Tasmania. This policy will be part of a national commitment to implement the Nationally consistent approach for access to and the utilisation of Australia’s native genetic and biochemical resources. The policy aims to attract bioprospecting activity to Tasmania and ensure that companies entering the state are equipped with a ‘one-stop-shop’ for quality information and easy access to licensing permits. More information on the Tasmanian Government’s policy position will be available shortly. For enquiries, please contact the Executive Officer, Access to Biological Resources Project, Department of Primary Industries and Water on 6233 4031 or email biological. firstname.lastname@example.org. A Tasmanian delegation consisting of Vic Phillips from Selborne Biological Services, Professor David McNeil from the Tasmanian Institute of Agricultural Research (TIAR) and Dr Glenn Jacobson from the University of Tasmania (UTAS) and newly-registered company Xderma Pty Ltd, attended BIO 2009 in Atlanta from 18–21 May 2009. The delegation was led by Nigel Blundell, Manager Science and Technology from the Department of Economic Development and Tourism. Early indications are encouraging with Selborne Biological Services, TIAR, UTAS and Xderma all having successful business matching meetings. South Australia Recently, SA has been buzzing with money talk and new buildings. In May, “Surviving the GFC; Winning with private equity” was discussed at the fourth Venture Capital SA Private Equity Forum. Also in May, the Angel Capital Education Foundation and BioAngels facilitated a day-long overview seminar on angel investing. In April, AusBiotech member CPR Pharma Services closed a $2.52m deal, positioning the company for future business expansion and infrastructure purchases. CPR offers specialised services supporting drug development for the biotechnology and pharmaceutical industries. In the south, the Flinders University Department of Medical Biotechnology has a new home. The new building offers state-of-the-art laboratories and teaching facilities and AusBiotech was invited to the Department’s ‘warming’ event on 8 May. Several past Flinders graduates, including SA Branch Chair Dr Justin Coombs and I, were very impressed with the facility and the resources for current and new students. TAFE SA, Veterinary and Applied Science invited AusBiotech to join their Laboratory Operations Enterprise Advisory Group in April. After this meeting, I was invited to tour their new facilities at the Gilles Plains Campus. AusBiotech member, Vivopharm, is also represented on this committee. The March BioBreakfast saw invited speaker Jefferson Harcourt from Grey Innovation discuss reducing development risk for medical device companies. The well-attended event was held at the Lion Function Centre and was proudly sponsored by Phillips Ormonde Fitzpatrick. Finally, the SA Branch of AusBiotech would like to congratulate long-time AusBiotech supporter, Dr Michael Crouch, for being awarded the prestigious 2009 Advancing BioBusiness Award. Michael is the Chief Scientific Officer at AusBiotech member company, TGR Biosciences. For further information contact: Dr Olgatina Bushi, SA Industry Development Officer email@example.com Xderma Pty Ltd develops ointments using a native Tasmanian plant to treat pastern dermatitis (greasy heel) in horses and psoriasis in humans. 58 Australasian BioTechnology Volume 19 • Number 2 • July 2009